- CA$32.18m
- CA$30.32m
- CA$25.17m
- 96
- 78
- 63
- 93
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20.6 | 24.4 | 24.5 | 28.9 | 25.2 |
Cost of Revenue | |||||
Gross Profit | 4.86 | 7.02 | 6.24 | 8.76 | 7.02 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.7 | 21.7 | 22.4 | 26.2 | 22.1 |
Operating Profit | -1.02 | 2.72 | 2.07 | 2.64 | 3.06 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.03 | 2.68 | 2.03 | 2.38 | 2.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.3 | 2.09 | 1.3 | 1.61 | 2.18 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.3 | 2.09 | 1.3 | 1.61 | 2.18 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.3 | 2.09 | 1.3 | 1.61 | 2.18 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.034 | 0.047 | 0.084 | 0.104 | 0.139 |